| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5713670 | American Journal of Otolaryngology | 2017 | 5 Pages |
Abstract
HPV-positive HNSCC in the veteran population has a significantly improved prognosis relative to similarly staged patients with HPV-negative disease. This study demonstrates that the primary treatment modality - chemoradiation, radiation therapy, or surgery - does not impact overall survival among veterans with HPV-positive HNSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Aaron J. Feinstein, Sophie G. Shay, Elena Chang, Michael S. Lewis, Marilene B. Wang,